# A Study of Participants in Australia Who Have Non-small Cell Lung Cancer Being Treated With Nivolumab

> **NCT03804554** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 503 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **OTHER:** Non-Interventional

## Key facts

- **NCT ID:** NCT03804554
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-03
- **Primary completion:** 2021-08-12
- **Final completion:** 2021-08-12
- **Target enrollment:** 503 (ACTUAL)
- **Last updated:** 2022-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03804554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03804554, "A Study of Participants in Australia Who Have Non-small Cell Lung Cancer Being Treated With Nivolumab". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03804554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*